Clinical Trial Update: Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing AVT16 with Entyvio in ulcerative colitis has been terminated; the update does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• AVT16
• Entyvio (vedolizumab)

Snippet

Sponsor: Alvotech Swiss AG | Conditions: Ulcerative Colitis | Phase 3 | Status: TERMINATED